Division of Hematology and Hematologic Malignancies, University of Utah-Huntsman Cancer Hospital is a clinical research site located in Salt Lake City, Utah, United States 84112.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Division of Hematology and Hematologic Malignancies, University of Utah-Huntsman Cancer Hospital has participated in 1 clinical trials.
Therapeutic areas: Relapsed/Refractory Acute Leukemia.
Sponsors: Syndax Pharmaceuticals.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Division of Hematology and Hematologic Malignancies, University of Utah-Huntsman Cancer Hospital has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Division of Hematology and Hematologic Malignancies, University of Utah-Huntsman Cancer Hospital has 1 clinical trials on record. Their work covers Relapsed/Refractory Acute Leukemia.
Division of Hematology and Hematologic Malignancies, University of Utah-Huntsman Cancer Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.